Suppr超能文献

肺癌患者的肾功能评估。

Estimation of renal function in lung cancer patients.

机构信息

Pharmacy Department, University Clinic Golnik, Golnik 36, 4204 Golnik, Slovenia.

出版信息

Lung Cancer. 2012 Jun;76(3):397-402. doi: 10.1016/j.lungcan.2011.11.016. Epub 2011 Dec 15.

Abstract

INTRODUCTION

In lung cancer patients treated with chemotherapy, renal function is an important parameter to be monitored. Since measurement of renal function with either isotope or creatinine clearance is time consuming and expensive, we evaluated which of the following equations: Cockcroft-Gault (CG), Wright, modification of diet in renal disease equation (MDRD), MDRD adjusted for body surface area (BSA) and chronic kidney disease epidemiology collaboration (CKD-EPI) best resembles endogenous creatinine clearance (ECC) and could therefore replace its measurement in clinical practice.

METHODS

218 lung cancer patients, who had their 24-h creatinine secretion in urine measured prior to the start of any chemotherapy, were included. Estimation of renal function was calculated and compared to ECC.

RESULTS

There were no major differences in the performance of the tested equations. Mean percentage error of more than 20% and general underestimation was common to all equations. Wright equation performed best although it describes only 43% of ECC variability. Mean measured ECC was 94 mL/min (95% confidence interval [CI]: 90-98 mL/min) and 90 mL/min for Wright equation (95% CI: 87-93 mL/min) (Supp. Fig. 3). MDRD and CKD-EPI equation performed poorest since they do not include any body size descriptor. Large deviations of differences were observed, with a median standard deviation of more than 20% and deviations from ECC exceeding 100%. Wright equation performed best, whereas, despite their leading role in the detection of renal diseases, the MDRD and CKD-EPI equation performed poorest since they do not include any body size descriptor. In the range of ECC<50 mL/(min×1.73 m(2)), the CG equation most often detected a contraindication for cisplatin use. Differences between ECC and calculated values correlated with patients' weight, BSA and body mass index when these were not included in the equation itself.

CONCLUSIONS

In evaluating the renal function of lung cancer patients, equations adjusted for body size descriptors should be preferred. Estimated renal function should be interpreted against the characteristics of patient's body size and special attention is needed when these are reaching the extremes.

摘要

简介

在接受化疗的肺癌患者中,肾功能是需要监测的重要参数。由于同位素或肌酐清除率测量肾功能既耗时又昂贵,我们评估了以下哪种方程: Cockcroft-Gault(CG)、Wright、改良肾脏病饮食方程(MDRD)、体表面积校正的 MDRD(BSA)和慢性肾脏病流行病学合作研究(CKD-EPI)最能反映内源性肌酐清除率(ECC),因此可以在临床实践中替代其测量。

方法

纳入 218 例在开始任何化疗前测量了 24 小时尿肌酐排泄的肺癌患者。计算肾功能的估计值并与 ECC 进行比较。

结果

所测试的方程在性能上没有太大差异。超过 20%的平均误差和普遍低估是所有方程的共同特点。Wright 方程表现最好,尽管它仅描述了 ECC 可变性的 43%。平均测量的 ECC 为 94 mL/min(95%置信区间[CI]:90-98 mL/min),Wright 方程为 90 mL/min(95%CI:87-93 mL/min)(补充图 3)。MDRD 和 CKD-EPI 方程表现最差,因为它们不包括任何身体大小描述符。观察到差异的较大偏差,中位数标准偏差超过 20%,与 ECC 的偏差超过 100%。Wright 方程表现最好,而尽管在检测肾脏疾病方面处于领先地位,但 MDRD 和 CKD-EPI 方程表现最差,因为它们不包括任何身体大小描述符。在 ECC<50 mL/(min×1.73 m2)范围内,CG 方程最常检测到顺铂使用的禁忌症。当这些不在方程本身中时,ECC 和计算值之间的差异与患者的体重、BSA 和体重指数相关。

结论

在评估肺癌患者的肾功能时,应优先选择调整身体大小描述符的方程。应根据患者的身体大小特征来解释估计的肾功能,当这些特征达到极限时需要特别注意。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验